Strategic Advocates’s New York Times NYT Stock Holding History

Strategic Advocates’s Portfolio NYT Stock Details NYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-116	Closed	-$8.09K	–	494
2025 Q4	$8.09K	Hold	116	–	–	﹤0.01%	391
2025 Q3	$6.66K	Buy	+116	New	+$6.62K	﹤0.01%	384

Other funds holding NYT

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Linonia Partnership New York $5.6B AUM 1.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCP

Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Strategic Advocates's NYT Position: Q1 2026 in Review

Strategic Advocates sold out of New York Times (NYT) in Q1 2026, closing a stake of 116 shares — an estimated $8.09K sold.

Strategic Advocates first reported a position in NYT in Q3 2025 and held it in 2 quarters. The position peaked at $8.09K in Q4 2025. 629 funds tracked by Wall St. Rank hold NYT as of Q1 2026.

Strategic Advocates reported no remaining New York Times position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 116 New York Times shares in Q1 2026, an estimated $8.09K.
Strategic Advocates first reported a position in New York Times in Q3 2025 and held it in 2 quarters.
Strategic Advocates's New York Times position peaked at $8.09K in Q4 2025.
629 funds tracked by Wall St. Rank held New York Times as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.